Apatinib for Advanced Lung Squmamous Carcinoma

Clinical trial NCT03725423 · UNKNOWN

Trial details

NCT number: NCT03725423
Sponsor: Xuzhou Central Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Lung Squamous Cell Carcinoma

Start date: 2018-10-01
Primary completion: 2019-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.